Researchers have developed an artificial intelligence (AI)-powered electrocardiogram (ECG) tool capable of identifying hidden signs associated with sudden cardiac death (SCD) before symptoms appear, offering a potential breakthrough in the early detection of one of the world’s leading causes of unexpected mortality.

The study found that the AI model could identify individuals at elevated risk of sudden cardiac death by detecting subtle ECG patterns that are often undetectable through conventional clinical interpretation. Notably, more than 86% of people flagged as high risk by the AI would not have been identified using current risk assessment methods, suggesting the technology could uncover previously hidden cardiovascular risks.

Researchers trained and validated the AI system using large-scale ECG datasets to recognize complex electrical signatures associated with life threatening heart rhythm disorders. The findings indicate that AI-assisted ECG analysis could complement existing diagnostic approaches by helping clinicians identify patients who may benefit from closer monitoring, preventive therapies or further cardiac evaluation.

Sudden cardiac death remains a major global public health challenge, accounting for an estimated 4–5 million deaths worldwide each year. It often occurs without prior warning and is commonly caused by ventricular arrhythmias, structural heart disease or inherited cardiac conditions. While current screening methods focus on factors such as reduced heart function, previous heart attacks and family history, many individuals who experience sudden cardiac death do not meet these traditional high risk criteria.

Healthcare experts believe artificial intelligence has the potential to transform cardiovascular medicine by improving early diagnosis, risk prediction and personalized patient care. AI  driven ECG analysis is increasingly being explored to detect conditions such as atrial fibrillation, heart failure, cardiomyopathy and silent coronary artery disease, enabling earlier clinical intervention.

Researchers cautioned that the technology is not intended to replace clinical judgment and requires further validation through prospective clinical trials before routine implementation. However, they noted that AI enabled screening could become an important tool in preventive cardiology, particularly for identifying high risk individuals who may otherwise remain undiagnosed.

Experts have welcomed the findings, stating that integrating artificial intelligence into routine ECG interpretation could significantly enhance the early detection of life threatening cardiac conditions. If validated in real world clinical settings, the technology could improve preventive care, reduce sudden cardiac deaths and support more personalized cardiovascular risk management.